We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score.
- Authors
Kamal, Arif H; Loprinzi, Charles L; Reynolds, Carol; Dueck, Amylou C; Geiger, Xochiquetzal J; Ingle, James N; Carlson, Robert W; Hobday, Timothy J; Winer, Eric P; Goetz, Matthew P
- Abstract
Half of all breast cancers are early stage, lymph node negative, and hormone receptor positive. A 21-gene (Oncotype DX®; Genomic Health, Inc., Redwood City, CA) recurrence score (RS) is prognostic for recurrence and predictive of chemotherapy benefit. We explored the ability of oncologists to predict the RS using standard prognostic criteria.
- Publication
The oncologist, 2011, Vol 16, Issue 10, p1359
- ISSN
1549-490X
- Publication type
Journal Article
- DOI
10.1634/theoncologist.2011-0048